newsfilter
← Latest News
Business Wire·

Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments

New CEO Michael Severino, MD, brings extensive biopharma leadership and a proven track record of advancing innovation, building franchises, and delivering growth Net product revenues for the second quarter 2026